AADI (Aadi Bioscience Inc) Projected Sales Volume

Corporate emblem and logo of Aadi Bioscience, Inc. (AADI)

Aadi Bioscience (AADI) aims to secure a leadership position in the treatment of rare sarcomas, outpacing major industry players. The company is engaged in a fierce battle for patents and scientific talent. Demand for its products remains independent of economic conditions, ensuring stability. The company's future sales indicator demonstrates the current capital trajectory, where the value of 0.03 reflects this status.

AADI - Aadi Bioscience, Inc. Company Expected Sales Volume over the range 07/04/2022 - 03/19/2025

Summary analytical data breakdowns for Aadi Bio (AADI)

- stock value and consensus price forecast:
Price Chart Aadi Bioscience|AADI - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Aadi Bioscience Inc|AADI - Full Takeover Company Value
- book capitalization information:
Book Value per Share Aadi Bioscience|AADI - Total Stockholders' Equity|Market Cap to Net Assets Ratio aadibio.com|AADI - Aggregate Business Assets
- debt and liquidity data:
Total Debt to Capital Aadi Bioscience|AADI - Long-Term Liabilities to Capital|Short-Term Debt to Capital Aadi Bioscience|AADI - Company Aggregate Debt|Debt to Book Value Aadi Bioscience Inc|AADI - Company Long-Term Loans and Borrowings|Company Current Liabilities Aadi Bioscience|Quick Ratio aadibio.com
- earnings and market ratios statistics:
AADI - Final Profit|Projected Future Earnings Aadi Bioscience|AADI - Market Cap to Earnings|Future Price to Earnings Aadi Bioscience|AADI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Aadi Bioscience Inc|AADI - Operating profit EBITDA|Earnings per share for the last twelve months Aadi Bioscience|AADI - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aadibio.com|AADI - Earnings per share growth rate in current year|Earnings growth forecast for next year Aadi Bioscience
- sales and revenue data:
AADI - Revenue and Sales Volume|Projected Sales Volume Aadi Bioscience|AADI - P/S Multiple|Forward P/S Multiple Aadi Bioscience Inc
Summary company analytics:Aadi Bioscience, Inc. AADI
Brand item of Aadi Bio

Future sales volume determines expected revenue, serving as a fundamental benchmark for operating income. The calculation model offsets short-term volatility, revealing a sustainable trend in cash inflows. By analyzing the company's planned sales levels, an investor assesses the business's scaling potential. For Aadi Bioscience (AADI), this indicator reflects the commercial success of integrating the drug FYARRO into clinical protocols. Growth in this metric confirms the demand for targeted therapy for rare oncological diseases.

Direct competitors

Company Projected Revenue Genmab A/S (GMAB)|EXEL (exelixis.com) - Company Future Revenue|Projected Sales Volume NUVL (Nuvalent)|Company Sales Forecast Kymera Therapeutics, Inc.|IDEAYA Bio - Projected Sales Volume|Company Expected Sales Volume Enliven Corp|ORIC (ORIC Pharmaceuticals) - Company Future Sales Volume|RLAY: Company Projected Revenue Volume|NRIX (Nurix Therapeutics, Inc.) - Projected Sales Volume|Company Expected Sales Volume Tyra Biosciences Inc TYRA|Projected Sales Volume VSTM|Monte Rosa Corp - Company Revenue Forecast|Cullinan Therapeutics - Company Future Sales Volume|Company Future Revenue IMRX|CCCC: Company Future Sales Volume|Black Diamond Therapeutics, Inc. - Company Projected Revenue Volume|RPTX: Projected Sales Volume|PMV Pharmaceuticals, Inc - Company Future Revenue|KPTI (Karyopharm Therapeutics, Inc.) - Projected Sales Volume|Company Expected Sales Volume Propanc Biopharma, Inc. PPCB|Company Projected Revenue Bio Green Med Solution (BGMS)|ALRN (aileronrx.com) - Company Future Revenue|Projected Sales Volume BPMC (Blueprint Medicines Corporation)|Projected Sales Volume GlycoMimetics Inc. GLYC|SWTX - Company Projected Revenue